{"id":88477,"date":"2021-10-07T18:45:39","date_gmt":"2021-10-07T22:45:39","guid":{"rendered":"http:\/\/stateofthenation.co\/?p=88477"},"modified":"2021-10-07T18:46:00","modified_gmt":"2021-10-07T22:46:00","slug":"quite-scary-dod-data-analysis-reveals-accelerated-ade-in-vaccinated","status":"publish","type":"post","link":"http:\/\/stateofthenation.co\/?p=88477","title":{"rendered":"QUITE SCARY! DoD Data Analysis Reveals Accelerated ADE In Vaccinated"},"content":{"rendered":"

\"\"<\/a><\/p>\n

\n

DoD Data Analysis Reveals Accelerated ADE In Vaccinated<\/h1>\n

By Michelle Edwards
\nUncoverdc.com<\/p>\n

A Department of Defense (DoD<\/a>) program called \u201cProject Salus\u201d analyzed data<\/a> on 5.6 million Medicare beneficiaries aged 65 or older and found that most COVID-19 hospitalizations are among fully vaccinated patients, with numbers increasing as the weeks pass. <\/span>In cooperation with the Joint Artificial Intelligence Center (JAIC<\/a>), the study was presented by DoD partner Humetrix<\/a>. <\/span>Alarmingly, the data backs up what experts have predicted<\/a> for months\u2014<\/span>that mass vaccination against COVID-19 will result in the mutation and strengthening of SARS-CoV-1, a phenomenon called Antibody-Dependent Enhancement (ADE<\/a>), thus driving up the rate of infection and spread of the virus.<\/p>\n

Project Salus data suggests that the majority of COVID-19 infections<\/a> in study cohorts occur among those fully vaccinated, with outcomes worsening over time. Additionally, based on this analysis, individuals who have contracted and recovered from COVID-19 boast natural immunity, which offers the strongest protection against breakthrough infection.<\/p>\n

\"analysis\"
Slide 17, Humetrix Presentation<\/figcaption><\/figure>\n

The complete analysis, titled \u201cEffectiveness of mRNA COVID-19 vaccines against the Delta variant among 5.6M Medicare beneficiaries 65 years and older,\u201d was presented on September 28, 2021, by <\/span>Humetrix<\/span>. An innovator in \u201cconsumer-centered mobile platforms\u201d for over twenty years, Humetrix is <\/span>under contract<\/span><\/a> with the JAIC and the DoD to \u201cconduct COVID-19 surveillance and population risk mapping in the highest risk Medicare population for severe COVID-19.\u201d In a January 11, 2021 press release, the company explained:<\/span><\/p>\n

\u201cThe Humetrix Platform is now configured for COVID-19 vaccine safety, and efficacy monitoring in the Medicare population targeted to be vaccinated in priority. (see this <\/span><\/em>MedRxiv pre-print<\/span><\/em><\/a> publication and this\u00a0<\/span><\/em>JAMA article<\/span><\/em><\/a> to learn more).\u201d<\/span><\/em><\/p>\n